Empagliflozin did not reduce mortality for HF after MI regardless of T2D status Presented ByProf. Javed Butler, University of Mississippi, USA TrialEMPACT-MI ConferenceHFA 2024 TypePeer-reviewed article 16 July 2024 16:49
Meet the Trialist: The EMPACT-MI trial findings ExpertProf. Javed Butler TrialPhase 3, EMPACT-MI ConferenceACC 2024 15 May 2024 15:33